Hide Board Information

Show Board Information

Reata Pharmaceuticals Inc. RETA

Board Mod: Add me as mod

Asst Mods:

Last Post: 07/28/2023 4:21:34 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 1

Reata Pharmaceuticals Inc. (NASDAQ: RETA) Stock Message Board

1. RETA Company Profile

    

2. RETA Time & Sales

    

3. RETA Recent News

    

4. RETA Filings

    

5. RETA Financials

    

6. RETA Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

6	$RETA 54% v12,3M c167.19 f37,551M H167.24	znewcar1	07/28/2023 4:21:34 PM
5	$RETA 20% v3,4M C95.36 f37,5M H96.115	znewcar1	05/24/2023 11:42:39 PM
4	RETA 21% v5,3M c27.07 f36,5M H27.82 Haft28.97	znewcar1	09/07/2022 8:37:50 PM
3	RETA 25% v2,9M c32.74 f36,4M H32.9	znewcar1	02/28/2022 6:46:42 PM
2	RETA 23% v2,7M c102.63 f36,2M	znewcar1	05/19/2021 11:08:46 PM
1	RETA 32% v1,3M c174.66 f33,6M H.175.52 EOD	znewcar1	11/09/2020 5:45:04 PM

Recent Articles

• Highlights of Week 17: Progress Under Trump’s Leadership
• TaskUs Shareholders Invited to Explore Legal Options Against Buyout
• Exploring Skechers' Recent Merger and Shareholder Concerns
• Legal Actions and Shareholder Rights: Ibotta Updates
• Assessing Legal Options for Iovance Biotherapeutics Investors
• Fractyl Health's Rejuva® Therapy Promises New Hope for Obesity
• Malai Unveils New Ice Cream Shop in Philadelphia with Flavor
• Destination XL Expands Presence with New Store Opening
• Understanding the Art of Giving for a Change in Humanity
• Çelebi Aviation's Commitment to ETHICS and Compliance
• Arcadis Achieves Key Milestones with Shareholder Support and Dividend Approval
• CHAI's Rapid Growth Positions It for Incredible Valuation Spike
• Revolutionary Advances in Treating Resistant Hypertension
• Revolutionary Advances in Hypertension Management for Patients
• GMI Cloud Expands Headquarters to Propel AI Innovation
• Important Update for Investors in Compass Diversified Holdings
• Understanding the Iovance Biotherapeutics Class Action Lawsuit
• Investors Alert: Class Action Against Viatris Inc. - VTRS
• Investors Urged to Act on NET Power Class Action Lawsuit
• Unlock Daily Passive Income with Leading Cloud Mining Firm
• Unlocking the Future of Cloud Mining with ALL4 Mining
• WuXi Biologics Celebrates Milestone Approval of Innovative Therapy
• CureGene's CG-0416: A Revolutionary Approach to Obesity Management
• Transformative Success: Silver Star Properties' Self-Storage Growth
• Light Energia S.A. Concludes Cash Tender Offer with Key Results
• SHARC Energy Secures Vital Short-Term Funding for Growth
• Franno's Debut Album: A New Era for Latin Music Enthusiasts
• GoldHaven Resources Provides Important Project Update
• Lasola's Market Sold: A New Chapter for Community Deli
• A Deep Dive into Consensus 2025 and Future Events
• SolarMax Technology Posts Strong Q1 Results, Sees Growth Ahead
• Texas Southern University Celebrates One Year of Progress
• Groundbreaking Blood Test Receives FDA Nod for Alzheimer's Aid
• Fintiv's Legal Triumph Against Apple in Patent Dispute
• Talisker Resources Secures Up to $3 Million in Funding
• Celebrating Community Spirit: LGI Homes' Service Impact Day
• NextGen Digital Platforms Achieves Successful Funding Milestone
• Breakthrough in Alzheimer's Testing with FDA's Approval
• Eldorado Gold Corporation Faces Investigation Over Investor Claims
• Iovance Biotherapeutics Secures New Opportunities for Growth
• North American Construction Group Reports 2025 Shareholder Votes
• Hi-View Resources Implements Share Consolidation for Growth
• Zeigler Auto Group Expands Luxury Portfolio with Acquisition
• Fashion Footwear LLC Wins Landmark Case Against Iconix Brand Group
• Vanda Pharmaceuticals to Present Insights at Key Summit 2025
• Unlock Daily Earnings with Savvy Mining and Dogecoin Insights
• Caliber Achieves Compliance with Key Nasdaq Listing Standards
• Aventis Energy Initiates Strategic Marketing Partnership
• LOBO EV Technologies Navigates Nasdaq Compliance Challenges
• Rivalry Corp. Updates on Management Cease Trade Order Status